Alto Neuroscience, Inc. (ANRO)
24.56
+0.53
(+2.21%)
USD |
NYSE |
Oct 09, 11:52
Alto Neuroscience Total Liabilities (Quarterly) : 34.82M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.82M |
| March 31, 2026 | 32.89M |
| December 31, 2025 | 33.55M |
| September 30, 2025 | 35.45M |
| June 30, 2025 | 34.46M |
| March 31, 2025 | 32.82M |
| December 31, 2024 | 26.08M |
| September 30, 2024 | 26.56M |
| Date | Value |
|---|---|
| June 30, 2024 | 17.58M |
| March 31, 2024 | 16.82M |
| December 31, 2023 | 158.30M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 89.26M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 254.07M |
| Shareholders Equity (Quarterly) | 219.25M |
| Debt to Equity Ratio | 0.1062 |
| Current Ratio | 14.85 |
| Net Debt Paydown Yield | 0.07% |